Evidence map›Paper›PMID 24913017›Full record

ArticleJournal of epidemiology and community health2014

Adequate and anticipatory research on the potential hazards of emerging technologies: a case of myopia and inertia?

Steffen Foss Hansen, David Gee

Erratum issuedAbstract read
In one paragraph

Article in Journal of epidemiology and community health, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

2 authors.

Steffen Foss HansenDTU Environment, Technological University of Denmark, Kgs. Lyngby, Denmark.
David GeeScience, Policy and Emerging Issues, European Environment Agency, Copenhagen.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

History confirms that while technological innovations can bring many benefits, they can also cause much human suffering, environmental degradation and economic costs. But are we repeating history with new and emerging chemical and technological products? In preparation for volume 2 of 'Late Lessons from Early Warnings' (European Environment Agency, 2013), two analyses were carried out to help answer this question. A bibliometric analysis of research articles in 78 environmental, health and safety (EHS) journals revealed that most focused on well-known rather than on newly emerging chemicals. We suggest that this 'scientific inertia' is due to the scientific requirement for high levels of proof via well replicated studies; the need to publish quickly; the use of existing intellectual and technological resources; and the conservative approach of many reviewers and research funders. The second analysis found that since 1996 the funding of EHS research represented just 0.6% of the overall funding of research and technological development (RTD). Compared with RTD funding, EHS research funding for information and communication technologies, nanotechnology and biotechnology was 0.09%, 2.3% and 4% of total research, respectively. The low EHS research ratio seems to be an unintended consequence of disparate funding decisions; technological optimism; a priori assertions of safety; collective hubris; and myopia. In light of the history of past technological risks, where EHS research was too little and too late, we suggest that it would be prudent to devote some 5-15% of RTD on EHS research to anticipate and minimise potential hazards while maximising the commercial longevity of emerging technologies.

Indexed as

Biomedical ResearchDiffusion of InnovationEnvironmental HealthHazardous SubstancesTechnologyBibliometricsEnvironmental ExposureEnvironmental PolicyHumansInformation DisseminationResearch Support as TopicRisk AssessmentRisk ManagementHazardous SubstancesEnvironmental HealthEthicsPolicyPublic Health Policy

Identifiers

PMID24913017
PMCPMC4145456

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.